FDA approves Novartis $475,000 cancer treatment

It's for aggressive leukemia in children and young adults.  It's a fancy procedure actually, the patient's blood is drawn, its T-cells separated and then genetically modified, and then injected back into the patient.  Sounds pretty costly.  And it is.  I don't want to answer the question "Is a human life worth $475,000?"  Nor do I want to have to pay $475,000 to stay alive.  Nor do I want to die, at least not just yet.  Clearly I have some unresolved philosophical issues here.   Norvartis calls this product/procedure "Kymriah".